ONTARGET^® trial: new evidence on the prevention and management of diabetes

Sunday 7th September 2008

ONTARGET^® trial: new evidence on the prevention and management of diabetes

Rome, Italy

The following presentations made at the of the Annual Meeting of the European Association for the Study of Diabetes 2008 are available as webcasts under the respective links:

Welcome and introduction

Paolo Cavallo Perin

Addressing the vascular component in diabetes

Diethelm Tschöpe

Managing total cardiovascular risk in diabetes: results from ONTARGET^®

Paolo Cavallo Perin

Diabetes: effects of telmisartan - ONTARGET^® and PRoFESS^® in the context of other recent trials

Anthony Barnett

Metabolic effects of telmisartan and ramipril

Greg Fulcher

Panel discussion

Greg Fulcher

^* Telmisartan is currently only approved for the treatment of hypertension

These webcasts follow the presentations held on occasion of the Annual Meeting of the European Association for the Study of Diabetes 2008 congress between 7th - 11th September 2008. They are reproduced here for your personal information. Pursuant to our Terms of Use any sort of reproduction or downloading, in total or in part, is prohibited.